Learning Objectives
Upon completion of this activity, participants should be able to:
- Summarize data concerning the prevalence of HIV infection among women throughout the United States and the world
- Discuss issues concerning reproduction and contraception among HIV-infected women
- Explain efficacy results and adverse events related to the sex of participants from clinical trials with antiretrovirals
Topics covered include:
- Introduction
- The HIV Epidemic in the United States
- Attitudes Concerning Reproduction Issues Among HIV-infected Women
- Antiretroviral Drug Resistance in Pregnant Women
- Atazanavir Pharmacokinetics in Pregnancy and Postpartum
- Lopinavir/Ritonavir Exposure During Development: Data From the Antiretroviral Pregnancy Registry
- Pharmacokinetic Interactions Between Vicroviroc and Contraceptive Agents
- Pharmacokinetics of Etravirine by Sex of the Subject
- Differences in the Outcomes of Antiretroviral Clinical Trials Stratified by Sex of the Participants